Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamine; Metabolic Disorder”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableUnknownNCT00922688
What this trial is testing

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients

Who this might be right for
Colon Carcinoma
Medical Center Alkmaar 30
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Not applicableLooking for participantsNCT04883515
What this trial is testing

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.

Who this might be right for
ObesityInsulin Resistance
University Hospital, Rouen 110
Testing effectiveness (Phase 2)Study completedNCT03428217
What this trial is testing

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Calithera Biosciences, Inc 444
Post-approval studies (Phase 4)Study completedNCT00943020
What this trial is testing

Effects of Glutamine on Gastric Emptying

Who this might be right for
Starvation
University of Nottingham 15
Not applicableStudy completedNCT01467063
What this trial is testing

Glutamine and Insulin Sensitivity in Type I Diabetes

Who this might be right for
Type I Diabetes Mellitus
Nemours Children's Clinic 13
Not applicableStudy completedNCT03199638
What this trial is testing

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Autoimmune DiseasesDiabetes Mellitus+4 more
Nemours Children's Clinic 14
Early research (Phase 1)Study completedNCT02071862
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Who this might be right for
Solid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more
Calithera Biosciences, Inc 210
Not applicableUnknownNCT05255328
What this trial is testing

Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome

Who this might be right for
MELAS Syndrome
Hospital Universitario 12 de Octubre 9
Testing effectiveness (Phase 2)Study completedNCT03057600
What this trial is testing

Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast Cancer
Calithera Biosciences, Inc 52
Large-scale testing (Phase 3)Study completedNCT01832636
What this trial is testing

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

Who this might be right for
MalnutritionEnvironmental EnteropathyDiarrhea
Children's Hospital Medical Center, Cincinnati 112
Post-approval studies (Phase 4)Study completedNCT01552291
What this trial is testing

The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies

Who this might be right for
MalnourishmentGastrointestinal Tumors
Insel Gruppe AG, University Hospital Bern 42
Not applicableNot Yet RecruitingNCT07347613
What this trial is testing

Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study

Who this might be right for
Diabetes
Assistance Publique - Hôpitaux de Paris 450
Post-approval studies (Phase 4)Study completedNCT01831310
What this trial is testing

Nutrition for Colorectal Cancer Patients and Neutrophil Functions

Who this might be right for
MalnutritionColorectal Cancer
Kocaeli University 36
Not applicableStudy completedNCT04353869
What this trial is testing

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Who this might be right for
GlutamineDiabeticCardiovascular Complications
Assistance Publique - Hôpitaux de Paris 995
Not applicableStudy completedNCT04948138
What this trial is testing

Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome

Who this might be right for
MELAS Syndrome
Jesús González de la Aleja Tejera 9
Large-scale testing (Phase 3)WithdrawnNCT00338221
What this trial is testing

Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition

Who this might be right for
Diarrhea, Malnutrition
University of Virginia 108
Testing effectiveness (Phase 2)Ended earlyNCT03933410
What this trial is testing

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Who this might be right for
Urea Cycle Disorder
Kaleido Biosciences 13
Not applicableStudy completedNCT00673894
What this trial is testing

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Who this might be right for
Type 2 Diabetes
Garvan Institute of Medical Research 22
Not applicableStudy completedNCT05023499
What this trial is testing

Perioperative Glutamine Supplementation and Cachexia

Who this might be right for
Glutamine; Metabolic DisorderCachexia
National Taiwan University Hospital 550
Next Page